| Using immunotherapy to boost the abscopal effect W Ngwa, OC Irabor, JD Schoenfeld, J Hesser, S Demaria, SC Formenti Nature Reviews Cancer 18 (5), 313-322, 2018 | 965 | 2018 |
| Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation AM Martin, DN Cagney, PJ Catalano, BM Alexander, AJ Redig, ... JAMA oncology 4 (8), 1123-1124, 2018 | 283 | 2018 |
| Is everything we eat associated with cancer? A systematic cookbook review JD Schoenfeld, JPA Ioannidis The American journal of clinical nutrition 97 (1), 127-134, 2013 | 251 | 2013 |
| A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab RA Chandra, TJ Wilhite, TA Balboni, BM Alexander, A Spektor, PA Ott, ... Oncoimmunology 4 (11), e1046028, 2015 | 240 | 2015 |
| Frameshift events predict anti–PD-1/L1 response in head and neck cancer GJ Hanna, P Lizotte, M Cavanaugh, FC Kuo, P Shivdasani, A Frieden, ... JCI insight 3 (4), 2018 | 239 | 2018 |
| Neoadjuvant nivolumab or nivolumab plus ipilimumab in untreated oral cavity squamous cell carcinoma: a phase 2 open-label randomized clinical trial JD Schoenfeld, GJ Hanna, VY Jo, B Rawal, YH Chen, PS Catalano, ... JAMA oncology 6 (10), 1563-1570, 2020 | 231 | 2020 |
| Neoadjuvant and adjuvant pembrolizumab in resectable locally advanced, human papillomavirus–unrelated head and neck cancer: a multicenter, phase II trial R Uppaluri, KM Campbell, AM Egloff, P Zolkind, ZL Skidmore, ... Clinical Cancer Research 26 (19), 5140-5152, 2020 | 231 | 2020 |
| Incidence and demographic burden of HPV-associated oropharyngeal head and neck cancers in the United States BA Mahal, PJ Catalano, RI Haddad, GJ Hanna, JI Kass, JD Schoenfeld, ... Cancer epidemiology, biomarkers & prevention 28 (10), 1660-1667, 2019 | 161 | 2019 |
| Multicenter evaluation of the tolerability of combined treatment with PD-1 and CTLA-4 immune checkpoint inhibitors and palliative radiation therapy A Bang, TJ Wilhite, LRG Pike, DN Cagney, AA Aizer, A Taylor, A Spektor, ... International Journal of Radiation Oncology* Biology* Physics 98 (2), 344-351, 2017 | 159 | 2017 |
| Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? S Demaria, C Guha, J Schoenfeld, Z Morris, A Monjazeb, A Sikora, ... Journal for immunotherapy of cancer 9 (4), 2021 | 154 | 2021 |
| Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy AM Luoma, S Suo, Y Wang, L Gunasti, CBM Porter, N Nabilsi, J Tadros, ... Cell 185 (16), 2918-2935. e29, 2022 | 151 | 2022 |
| The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors LRG Pike, A Bang, BA Mahal, A Taylor, M Krishnan, A Spektor, ... International Journal of Radiation Oncology* Biology* Physics 103 (1), 142-151, 2019 | 143 | 2019 |
| Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD (L)-1 … JD Schoenfeld, A Giobbie-Hurder, S Ranasinghe, KZ Kao, A Lako, J Tsuji, ... The Lancet Oncology 23 (2), 279-291, 2022 | 142 | 2022 |
| Nivolumab is effective in mismatch repair–deficient noncolorectal cancers: Results from arm Z1D—A subprotocol of the NCI-MATCH (EAY131) study NS Azad, RJ Gray, MJ Overman, JD Schoenfeld, EP Mitchell, JA Zwiebel, ... Journal of Clinical Oncology 38 (3), 214, 2020 | 136 | 2020 |
| Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition GS Naik, SS Waikar, AEW Johnson, EI Buchbinder, R Haq, FS Hodi, ... Journal for immunotherapy of cancer 7, 1-17, 2019 | 133 | 2019 |
| Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy JD Schoenfeld, DJ Sher, CM Norris Jr, RI Haddad, MR Posner, ... International Journal of Radiation Oncology* Biology* Physics 82 (1), 308-314, 2012 | 130 | 2012 |
| Active immunotherapy induces antibody responses that target tumor angiogenesis J Schoenfeld, M Jinushi, Y Nakazaki, D Wiener, J Park, R Soiffer, ... Cancer research 70 (24), 10150-10160, 2010 | 103 | 2010 |
| Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review JD Schoenfeld, A Mahadevan, SR Floyd, MA Dyer, PJ Catalano, ... Journal for immunotherapy of cancer 3, 1-6, 2015 | 101 | 2015 |
| Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis HS Park, JD Schoenfeld, RB Mailhot, M Shive, RI Hartman, R Ogembo, ... Annals of oncology 24 (6), 1427-1434, 2013 | 99 | 2013 |
| The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: a Dana‐Farber/Brigham and Women’s Cancer Center multidisciplinary guideline A Sultan, GJ Hanna, DN Margalit, N Chau, LA Goguen, FM Marty, ... The Oncologist 22 (3), 343-350, 2017 | 95 | 2017 |
